Microfluidics Market by Product (Devices, Components (Chips, Sensors, Pump, Valves, and Needles), Application (IVD [POC, Clinical, Veterinary], Research, Manufacturing, Therapeutics), End User and Region - Global Forecast to 2025

マイクロフルイディクスの世界市場予測:製品別(デバイス、コンポーネント(チップ、センサー、ポンプ、バルブ、針))、用途別(IVD [POC、臨床、獣医]、研究、製造、治療)、エンドユーザー別、地域別

◆タイトル:Microfluidics Market by Product (Devices, Components (Chips, Sensors, Pump, Valves, and Needles), Application (IVD [POC, Clinical, Veterinary], Research, Manufacturing, Therapeutics), End User and Region - Global Forecast to 2025
◆商品コード:AST 7541
◆調査・発行会社:MarketsandMarkets
◆発行日:2020年5月20日
◆ページ数:287
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:分析・科学機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD4,950 ⇒換算¥514,800見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥691,600見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥847,600見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

MarketsandMarkets社はマイクロフルイディクスの世界市場が2020年157億ドルから2025年440億ドルまで、年平均22.9%成長すると予測しています。本調査レポートでは、マイクロフルイディクスの世界市場を詳細に調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、市場インサイト、製品別(マイクロ流体ベースデバイス、マイクロ流体コンポーネント)、用途別(インビトロ診断、製薬&生命科学研究・製造、治療)、エンドユーザー別(病院&診断センター、学術研究機関、製薬&バイオテクノロジー企業)、地域別、競争状況、企業概要などを含め、ご提供いたします。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・プレミアムインサイト
・市場概要
・市場インサイト
・マイクロフルイディクスの世界市場:製品別(マイクロ流体ベースデバイス、マイクロ流体コンポーネント)
・マイクロフルイディクスの世界市場:用途別(インビトロ診断、製薬&生命科学研究・製造、治療)
・マイクロフルイディクスの世界市場:エンドユーザー別(病院&診断センター、学術研究機関、製薬&バイオテクノロジー企業)
・マイクロフルイディクスの世界市場:地域別
・競争状況
・企業概要

“The microfluidics market is projected to grow at a CAGR of 22.9%.”
The global microfluidics market size is projected to reach USD 44.0 billion by 2025 from USD 15.7 billion in 2020, at a CAGR of 22.9% during the forecast period. The ability of the microfluidics technology to replicate all the functions of its traditional counterparts in various healthcare applications, such as drug delivery, point-of-care (POC) diagnostics, and clinical diagnostics, is resulting in its wider adoption across the globe. In addition to this, technological advancements, increasing focus on data precision & accuracy, fast returns on investment, and faster testing & improved portability through microfluidic chip miniaturization are driving growth of the microfluidics industry.

“In 2019, in-vitro diagnostics accounted for the largest share of the market.”
Based on the application, the in-vitro diagnostics segment accounted for the largest share of the microfluidics market in 2019. The large share of this segment can be attributed to the increasing integration of microfluidics with laboratory analytical instruments, growing need for portable diagnostic equipment, and increasing demand for point-of-care testing.

“In 2019, the hospitals & diagnostic centers segment accounted for the largest share of the market.”
Based on end-users, the hospitals & diagnostic centers segment accounted for the largest share of the microfluidics market in 2019. The large share of this segment is attributed to the increasing use of microfluidic-based diagnostic devices, increasing adoption of microfluidics for the rapid diagnosis of various chronic diseases, technological advancements, and the inherent advantages of microfluidics

“APAC is projected to witness the highest growth during the forecast period.”
The APAC microfluidics market is estimated to register the highest CAGR during the forecast period. Factors such as the growing geriatric population, growing per capita income, increasing investments in the healthcare industry, rising demand for advanced technologies, and the expansion of private-sector hospitals to rural areas in various countries in the region.

The breakdown of primary participants was as mentioned below:
• By Company Type: Tier 1–53%, Tier 2–26%, and Tier 3–21%
• By Designation: C-level–42%, Director Level–26%, and Others–32%
• By Region: North America–26%, Europe–35%, Asia Pacific–20%, Latin America–11%, Middle East & Africa–8%

The global microfluidics market is highly competitive, with a large number of global and local market players competing for higher market shares. Danaher Corporation (US), Thermo Fisher Scientific (US), PerkinElmer Inc. (US), Agilent Technologies (US), Bio-Rad Laboratories, Inc. (US), Becton, Dickinson and Company (US), F. Hoffmann-La Roche (Switzerland), Illumina, Inc. (US), Fluidigm Microfluidics (US), Abbott Laboratories (US), and QIAGEN (Netherlands) are some of the prominent players in the microfluidic-based devices market.

The prominent players in the global microfluidic components market include Parker-Hannifin Corporation (US), Fluigent SA (France), Idex Corporation (US), Camozzi Automation Spa Società Unipersonale (Italy), Gems Sensors and Control (US), Aignep S.P.A. (Italy), SMC Corporation (Japan), Dolomite Microfluidics (UK), Cellix Ltd. (Ireland), Elveflow (France), Microfluidic ChipShop (Germany), Micronit Microtechnologies (Netherlands), and MicroLiquid (Spain).
Research Coverage:
The report analyzes the various infusion pump devices and their adoption patterns. It aims at estimating the market size and future growth potential of the microfluidics market for different segments such as product, application, end user, and region. The report also includes an in-depth competitive analysis of the key players in this market, along with their company profiles, product offerings, and recent developments.
Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share. Firms purchasing the report could use one or any combination of the below-mentioned five strategies for strengthening the market.

This report provides insights on the following pointers:
• Market Penetration: Comprehensive information on the product portfolios offered by the top players in the microfluidics industry
• Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the microfluidics market
• Market Development: Comprehensive information on the lucrative emerging regions by product, application, end user, and region
• Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the microfluidics industry
• Competitive Assessment: In-depth assessment of market shares, growth strategies, and products of leading players in the microfluidics market

【レポートの目次】

TABLE OF CONTENTS

1 INTRODUCTION (Page No. – 24)
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION AND SCOPE
1.2.1 MARKETS COVERED
1.2.2 YEARS CONSIDERED FOR THE STUDY
1.3 CURRENCY
1.4 LIMITATIONS
1.5 STAKEHOLDERS

2 RESEARCH METHODOLOGY (Page No. – 29)
2.1 RESEARCH APPROACH
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Key data from primary sources
2.1.2.2 Key industry insights
2.2 MARKET SIZE ESTIMATION
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
2.4 ASSUMPTIONS FOR THE STUDY

3 EXECUTIVE SUMMARY (Page No. – 43)

4 PREMIUM INSIGHTS (Page No. – 48)
4.1 GROWTH POTENTIAL OF THE MICROFLUIDICS MARKET
4.2 ASIA PACIFIC: MICROFLUIDICS MARKET, BY END USER
4.3 MICROFLUIDICS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
4.4 MICROFLUIDICS MARKET, BY REGION
4.5 MICROFLUIDICS MARKET: DEVELOPING VS. DEVELOPED MARKETS

5 MARKET OVERVIEW (Page No. – 52)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Rising demand for point-of-care testing
5.2.1.2 Technological advancements
5.2.1.3 Increasing focus on data precision and accuracy
5.2.1.4 Fast returns on investment
5.2.1.5 Faster testing and improved portability through microfluidic chip miniaturization
5.2.1.6 Entry of new players and launch of new and advanced products
5.2.2 RESTRAINTS
5.2.2.1 Complex and time-consuming regulatory approval process
5.2.2.2 Incorporation of microfluidics into existing workflows
5.2.3 OPPORTUNITIES
5.2.3.1 Emergence of microfluidic-based 3D cell culture systems, such as organ-on-a-chip
5.2.3.2 Asia—a key growth hotspot
5.2.3.3 Expanding applications of drug delivery technologies
5.2.3.4 Growing applications of microfluidics
5.2.4 CHALLENGES
5.2.4.1 Standardization/commercialization of microfluidic devices

6 INDUSTRY INSIGHTS (Page No. – 61)
6.1 INTRODUCTION
6.2 INDUSTRY TRENDS
6.2.1 SHIFTING TREND TOWARDS EHEALTH DIAGNOSTICS WITH THE INTEGRATION OF MICROFLUIDICS-BASED POC DEVICES, EPIDERMAL ELECTRONICS,AND IOT
6.2.2 ADOPTION OF 3D PRINTING IN MICROFLUIDICS
6.2.3 SHIFTING TREND TOWARDS THE ADOPTION OF POLYMERS
6.2.4 UNIVERSITIES ACTIVELY INVESTING IN MICROFLUIDIC STARTUPS AND LARGE PLAYERS ACQUIRING SMALL PLAYERS
6.3 ANALYSIS OF PARENT MARKETS
6.4 EVOLUTION OF MICROFLUIDICS IN HEALTHCARE
6.5 VALUE CHAIN ANALYSIS
6.5.1 MICROFLUIDIC COMPONENTS PROCUREMENT MODEL OF MAJOR PLAYERS

7 MICROFLUIDICS MARKET, BY PRODUCT (Page No. – 74)
7.1 INTRODUCTION
7.2 MICROFLUIDIC-BASED DEVICES
7.2.1 INCREASING ADOPTION OF MICROFLUIDIC DEVICES OWING TO THE VARIOUS ADVANTAGES OFFERED BY THEM TO DRIVE MARKET GROWTH
7.3 MICROFLUIDIC COMPONENTS
7.3.1 MICROFLUIDIC CHIPS
7.3.1.1 Microfluidic chips reduce the analysis time by increasing automation and consume low volumes of samples
7.3.2 FLOW AND PRESSURE SENSORS
7.3.2.1 These devices offer a range of advantages, due to which they are increasingly used in laboratories and research institutes
7.3.3 FLOW AND PRESSURE CONTROLLERS
7.3.3.1 Due to high accuracy and control stability, pressure controllers are suitable as references for laboratories
7.3.4 MICROPUMPS
7.3.4.1 Need for precision in fluid control and device miniaturization has favored the growth of the micropumps market
7.3.5 MICROFLUIDIC VALVES
7.3.5.1 Valves are a vital component in microfluidic devices—a key factor driving market growth
7.3.6 MICRONEEDLES
7.3.6.1 Small size of microneedles leaves dermal nerves and blood vessels unaffected, ensuring a painless procedure
7.3.7 OTHER COMPONENTS

8 MICROFLUIDICS MARKET, BY APPLICATION (Page No. – 96)
8.1 INTRODUCTION
8.2 IN VITRO DIAGNOSTICS
8.2.1 POINT-OF-CARE TESTING
8.2.1.1 Point-of-care testing is the largest application segment in the microfluidics market for in vitro diagnostics
8.2.2 CLINICAL DIAGNOSTICS
8.2.2.1 Increase in viral outbreaks to drive growth in the clinical diagnostics segment
8.2.3 VETERINARY DIAGNOSTICS
8.2.3.1 Growing need for low-cost, rapid, and reliable diagnostic results in veterinary medicine to drive market growth
8.3 PHARMACEUTICAL AND LIFE SCIENCE RESEARCH AND MANUFACTURING
8.3.1 LAB ANALYTICS
8.3.1.1 Proteomic analysis
8.3.1.1.1 Increasing demand for rapid proteomic analysis for drug development is boosting the adoption of lab-on-a-chip devices
8.3.1.2 Genomic analysis
8.3.1.2.1 Increasing focus on the decoding of genomes to boost the adoption of microfluidics in genomics
8.3.1.3 Cell-based assays
8.3.1.3.1 Increasing focus on microfluidic cell-based assays for rapid drug development aids market growth
8.3.1.4 Capillary electrophoresis
8.3.1.4.1 Combination of microfluidic capillary electrophoresis with other technologies to drive overall market growth
8.3.2 MICRODISPENSING
8.3.2.1 Advantages such as less sample and reagent consumption and ease of operation drive the adoption of microdispensing systems
8.3.3 MICROREACTION
8.3.3.1 Increasing need for optimization in the research and production process using microfluidic techniques drives the market growth
8.4 THERAPEUTICS
8.4.1 DRUG DELIVERY
8.4.1.1 Expanding applications of microfluidic in development of drug delivery platform are a key driver for market growth
8.4.2 WEARABLE DEVICS
8.4.2.1 Increasing demand for microfluidics-integrated wearable devices for patient vital sign monitoring drives overall growth

9 MICROFLUIDICS MARKET, BY END USER (Page No. – 118)
9.1 INTRODUCTION
9.2 HOSPITALS AND DIAGNOSTIC CENTERS
9.2.1 HOSPITALS AND DIAGNOSTIC CENTERS ARE THE LARGEST END USERS OF MICROFLUIDICS
9.3 ACADEMIC AND RESEARCH INSTITUTES
9.3.1 USE OF MICROFLUIDICS IN RESEARCH IS EXPECTED TO INCREASE WITH GROWING FUNDING IN THE FIELD
9.4 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
9.4.1 INCREASING FOCUS ON LAUNCHING QUALITY DRUGS TO SUPPORT MARKET GROWTH

10 MICROFLUIDICS MARKET, BY REGION (Page No. – 126)
10.1 INTRODUCTION
10.2 NORTH AMERICA
10.2.1 US
10.2.1.1 The US dominates the North American microfluidics market
10.2.2 CANADA
10.2.2.1 Strong infrastructure and availability of funding for biomedical research will support market growth
10.3 EUROPE
10.3.1 GERMANY
10.3.1.1 Germany holds the largest share in the European market
10.3.2 FRANCE
10.3.2.1 Genomics and proteomics research is strongly supported by the government of France
10.3.3 UK
10.3.3.1 Increasing incidence of infectious diseases such as COVID-19 drives the growth of PoC testing and microfluidics
10.3.4 ITALY
10.3.4.1 Increasing demand for PoC testing aids market growth
10.3.5 SPAIN
10.3.5.1 Increasing incidence of infectious and chronic diseases drives the growth of the market
10.3.6 REST OF EUROPE
10.4 ASIA PACIFIC
10.4.1 CHINA
10.4.1.1 China holds a major share in the Asia Pacific microfluidics market
10.4.2 JAPAN
10.4.2.1 Adoption of technologically advanced laboratory analytical instruments in research to drive market growth in Japan
10.4.3 INDIA
10.4.3.1 Increasing pharma R&D and government funding in the biotechnology sector is a major source of market growth
10.4.4 REST OF ASIA PACIFIC
10.5 LATIN AMERICA
10.5.1 BRAZIL
10.5.1.1 Pharmaceutical & biologics QC to drive market growth in Brazil
10.5.2 MEXICO
10.5.2.1 Rising prevalence of chronic diseases drives the growth of the microfluidics market in Mexico
10.5.3 REST OF LATIN AMERICA
10.6 MIDDLE EAST & AFRICA

11 COMPETITIVE LANDSCAPE (Page No. – 203)
11.1 OVERVIEW
11.2 PRODUCT PORTFOLIO MATRIX
11.3 COMPETITIVE SITUATION AND TRENDS
11.3.1 PRODUCT LAUNCHES
11.3.2 PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS
11.3.3 ACQUISITIONS
11.3.4 EXPANSIONS
11.4 COMPETITIVE LEADERSHIP MAPPING
11.4.1 VISIONARY LEADERS
11.4.2 INNOVATORS
11.4.3 DYNAMIC DIFFERENTIATORS
11.4.4 EMERGING COMPANIES

12 COMPANY PROFILES (Page No. – 214)
(Business Overview, Products Offered, Recent Developments, SWOT Analysis, Strategic Overview, Competitive Analysis)*
12.1 PARKER-HANNIFIN CORPORATION
12.2 SMC CORPORATION
12.3 IDEX CORPORATION
12.4 FLUIGENT SA
12.5 DOLOMITE MICROFLUIDICS
12.6 AIGNEP S.P.A.
12.7 CAMOZZI AUTOMATION SPA SOCIETÀ UNIPERSONALE
12.8 ELVEFLOW
12.9 CELLIX LTD.
12.10 FORTIVE CORPORATION
12.11 DANAHER CORPORATION
12.12 THERMO FISHER SCIENTIFIC INC.
12.13 PERKINELMER, INC.
12.14 AGILENT TECHNOLOGIES, INC.
12.15 BIO-RAD LABORATORIES, INC.
12.16 BECTON, DICKINSON AND COMPANY
12.17 ILLUMINA, INC.
12.18 F. HOFFMANN-LA ROCHE LTD.
12.19 FLUIDIGM CORPORATION
12.20 ABBOTT LABORATORIES
*Business Overview, Products Offered, Recent Developments, SWOT Analysis, Strategic Overview, Competitive Analysis might not be captured in case of unlisted companies.



★調査レポート[マイクロフルイディクスの世界市場予測:製品別(デバイス、コンポーネント(チップ、センサー、ポンプ、バルブ、針))、用途別(IVD [POC、臨床、獣医]、研究、製造、治療)、エンドユーザー別、地域別] ( Microfluidics Market by Product (Devices, Components (Chips, Sensors, Pump, Valves, and Needles), Application (IVD [POC, Clinical, Veterinary], Research, Manufacturing, Therapeutics), End User and Region - Global Forecast to 2025 / AST 7541) 販売に関する免責事項
[マイクロフルイディクスの世界市場予測:製品別(デバイス、コンポーネント(チップ、センサー、ポンプ、バルブ、針))、用途別(IVD [POC、臨床、獣医]、研究、製造、治療)、エンドユーザー別、地域別] ( Microfluidics Market by Product (Devices, Components (Chips, Sensors, Pump, Valves, and Needles), Application (IVD [POC, Clinical, Veterinary], Research, Manufacturing, Therapeutics), End User and Region - Global Forecast to 2025 / AST 7541) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆